StockData

Ameresco vs Legence

AMRC and LGN side by side, both in industrials. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AMRC and LGN compare

Legence is the larger company, worth 2.8 times as much as Ameresco ($3.7B against $1.3B).

Legence scores higher on the StockData Score (6 against 2 for Ameresco), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAMRCLGN
Size and price
Market cap$1.3B$3.7B
Share price$24.68$34.18
Change, 1 year−21.7%2.6%
Change, 5 years−72.5%–
Beta (5Y)1.932.75
Employees1,6017,000
StockData Score
Total score26 (better)
Valuation score1 (better)0
Growth score02 (better)
Performance score02 (better)
Health score12 (better)
Dividend score00
Valuation
P/S–0.8×
P/B1.1× (better)5.4×
EV/EBITDA–16.1×
P/FCF–12.4×
FCF yield–8.1%
Fair value–$7.07
Margin of safety–−384%
Growth
Revenue growth (TTM)–84.2%
Profitability
Gross margin–19.1%
Operating margin–3.7%
Net margin–1.0%
FCF margin–6.9%
Return on equity–8.4%
Return on invested capital–9.3%
Financial health
Debt / equity1.581.51 (better)
Net debt / EBITDA–2.32
Interest coverage–2.5×
Current ratio1.67 (better)1.44
Altman Z-score0.592.16 (better)
Piotroski F-score–5
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions67.0%79.0%
Held by insiders40.1%47.1%
Insider net buying, 12 months$454K (better)−$2.5B
Short interest, % of float15.8%4.5%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.